The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999 - 2007
Year of publication: |
2013
|
---|---|
Authors: | Lichtenberg, Frank R. |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 14.2013, 1, p. 41-56
|
Subject: | USA | United States | Frankreich | France | Sterblichkeit | Mortality | Arzneimittel | Pharmaceuticals | Vergleich | Comparison |
-
Lichtenberg, Frank R., (2011)
-
Mortality and socioeconomic consequences of prescription opioids : evidence from state policies
Kaestner, Robert, (2019)
-
Identifying industry margins with price constraints : structural estimation on pharmaceuticals
Dubois, Pierre, (2018)
- More ...
-
"Industrial De-Diversification and Its Consequences for Productivity"
Lichtenberg, Frank R., (1990)
-
Lichtenberg, Frank R., (1989)
-
Spurious correlation in estimation of the health production function: A note
Akkoyunlu, Sule, (2010)
- More ...